First report of ampicillin and glycopeptide resistant Enterococcus faecium VanA bacteraemia in Greece.
Kouppari
G
G
Papadaki
H
H
Arida
C
C
Sakellariou
J
J
Legakis
N J
NJ
Papaparaskevas
J
J
D000368:Aged; D000667:Ampicillin / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016470:Bacteremia / Q000188:drug therapy / Q000378:metabolism / Q000382:microbiology*; D001426:Bacterial Proteins / Q000378:metabolism; D019729:Carbon-Oxygen Ligases / Q000378:metabolism; D016984:Enterococcus faecium / Q000187:drug effects* / Q000302:isolation & purification / Q000378:metabolism; D006020:Glycopeptides; D016908:Gram-Positive Bacterial Infections / Q000378:metabolism / Q000382:microbiology; D006115:Greece; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology*; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D006020:Glycopeptides; D010406:Penicillins; C071437:VanA ligase, Bacteria; D000667:Ampicillin; D019729:Carbon-Oxygen Ligases